Clinical Trial Update: Proteome-based Immunotherapy of Brain Metastases From Breast Cancer [Phase 2, Phase 3]

View source ↗

Summary

ClinicalTrials.gov update on a Phase 2/Phase 3 proteome-based immunotherapy trial for brain metastases from breast cancer; the current trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer with Brain Metastases

Snippet

Sponsor: NeuroVita Clinic | Conditions: Neoplasm Metastasis | Phase 2, Phase 3 | Status: UNKNOWN